|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||63.26 - 64.21|
|52-week range||54.58 - 68.24|
|Beta (5Y monthly)||0.82|
|PE ratio (TTM)||9.23|
|Earnings date||23 Feb 2020 - 27 Feb 2020|
|Forward dividend & yield||0.80 (1.24%)|
|Ex-dividend date||15 Dec 2019|
|1y target est||67.50|
Kaman Air Vehicles, a division of Kaman Corporation (NYSE: KAMN), today announced the advancement of its military and commercial K-MAX Unmanned Aerial Systems (UAS) programs. Kaman continues the development of the next generation of K-MAX UAS to support US Marine Corps future operating concepts. These logistics systems add flexibility and speed of distribution to all sizes of ground formations, while reducing the risk to our service men and women. "We have a combat proven system that sustained over 95% readiness while in the field. Looking ahead the next generation aircraft will leverage advancements in unmanned technologies and will add new autonomy capabilities," said Romin Dasmalchi, Senior Director Business Development of the Kaman Air Vehicles division.
Today we will run through one way of estimating the intrinsic value of Kaman Corporation (NYSE:KAMN) by projecting its...
Brady (BRC) is likely to gain from product offerings, improved efficiency in manufacturing facilities and investments to expand capacity. Also, its shareholder-friendly policies enhance its attractiveness.
Kaman Corp. (NYSE:KAMN) announced today that it has completed the previously announced acquisition of Bal Seal Engineering, Inc. ("Bal Seal"), a leader in the design, development, and manufacturing of highly engineered products including precision springs, seals, and contacts. With this acquisition, Kaman has significantly expanded its portfolio of engineered products and offerings while creating new opportunities to reach customers in medical technology, aerospace and defense, and industrial end markets.
Colfax (CFX) is likely to gain from acquired assets, healthy medical technology business and emerging market exposure. High costs, forex woes and huge debts are concerns.
Strong commercial aftermarket business, and solid demand for Honeywell's (HON) commercial fire and building management products are likely to drive its revenues.
Cintas (CTAS) is likely to gain from solid customer base, product portfolio, investment in technology and synergistic gains from acquired assets. Also, its shareholder-friendly policies bode well.
Colfax (CFX) benefits from acquisitions, productivity actions and product developments. However, escalating costs and a highly leveraged balance sheet are headwinds.
IDEX (IEX) benefits from the Velcora Holding AB buyout, solid product portfoliIDEX's (IEX) Prospects Encouraging Amid Esco and growth investments. However, escalating cost of sales is a concern.
Berry Global's (BERY) business unit plans to utilize cash on hand for the redemption of senior notes. The redemption is likely to help the company to lower its debt burden.
Actuant's (EPAC) fiscal Q1 earnings jump year over year supported by higher operating profits, reduced interest expenses and favorable tax rates.
Ingersoll-Rand (IR) is likely to continue benefiting from acquisitions and strength in its non-residential HVAC market. However, costs are witnessing a rise.
Kaman Corporation (NYSE:KAMN) today announced that James G. Coogan will become Vice President, Investor Relations & Business Development, effective January 1, 2020. In this role, he will report directly to Neal J. Keating, Chairman, President, and Chief Executive Officer.
Kaman Corporation (NYSE:KAMN) announced today that it has closed on an amended and restated $800 million credit facility. The new credit facility amends and restates the Company’s prior credit facility to, among other things: (i) extend the maturity date to December 2024; (ii) increase the aggregate amount of revolving commitments from $600 million to $800 million; (iii) modify the affirmative and negative covenants set forth in the facility; and (iv) effectuate a number of additional modifications to the terms and provisions of the facility, including its pricing.
Kaman's (KAMN) deal with Carestream Health for the production of complex composite assemblies will help it to expand customer base in the medical imaging domain.
Kaman Composites – Vermont, Inc. (KCV), a subsidiary of Kaman Corporation, announced the expansion of their medical imaging customer base with an agreement to manufacture complex composite assemblies for Carestream Health in support of their cutting edge DRX product line.